Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
15 | 90810354 | intron variant | C/T | snv | 0.28 |
|
0.700 | 1.000 | 1 | 2019 | 2019 | ||||||||||
|
0.882 | 0.160 | 15 | 90797765 | intron variant | A/G | snv | 0.37 |
|
Neoplasms; Stomatognathic Diseases; Otorhinolaryngologic Diseases | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||||
|
0.882 | 0.160 | 15 | 90797765 | intron variant | A/G | snv | 0.37 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.010 | 1.000 | 1 | 2009 | 2009 | |||||||
|
0.882 | 0.160 | 15 | 90797765 | intron variant | A/G | snv | 0.37 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.010 | 1.000 | 1 | 2009 | 2009 | |||||||
|
0.925 | 0.080 | 15 | 90813274 | intron variant | T/C | snv | 0.31 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.010 | 1.000 | 1 | 2009 | 2009 | |||||||
|
0.925 | 0.080 | 15 | 90813274 | intron variant | T/C | snv | 0.31 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.010 | 1.000 | 1 | 2009 | 2009 | |||||||
|
0.925 | 0.080 | 15 | 90813274 | intron variant | T/C | snv | 0.31 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2009 | 2009 | |||||||
|
0.925 | 0.080 | 15 | 90813274 | intron variant | T/C | snv | 0.31 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2009 | 2009 | |||||||
|
0.776 | 0.320 | 15 | 90761015 | stop gained | C/A;T | snv | 4.1E-06; 1.4E-04 | 1.7E-04 |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Neoplasms | 0.700 | 1.000 | 12 | 2007 | 2016 | ||||||
|
0.776 | 0.320 | 15 | 90761015 | stop gained | C/A;T | snv | 4.1E-06; 1.4E-04 | 1.7E-04 |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases; Immune System Diseases | 0.710 | 1.000 | 10 | 2007 | 2017 | ||||||
|
1.000 | 0.120 | 15 | 90784953 | stop gained | C/T | snv | 6.4E-05 | 3.5E-05 |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases; Immune System Diseases | 0.700 | 1.000 | 7 | 2000 | 2016 | ||||||
|
1.000 | 0.120 | 15 | 90763016 | stop gained | C/T | snv | 4.4E-05 | 8.4E-05 |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases; Immune System Diseases | 0.700 | 1.000 | 5 | 2007 | 2016 | ||||||
|
1.000 | 0.120 | 15 | 90760149 | stop gained | A/T | snv |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases; Immune System Diseases | 0.700 | 1.000 | 4 | 2007 | 2015 | ||||||||
|
1.000 | 0.120 | 15 | 90763016 | stop gained | C/T | snv | 4.4E-05 | 8.4E-05 |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Neoplasms | 0.700 | 1.000 | 4 | 2007 | 2016 | ||||||
|
1.000 | 0.120 | 15 | 90760657 | stop gained | G/A | snv | 7.0E-06 |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases; Immune System Diseases | 0.700 | 1.000 | 3 | 2007 | 2018 | |||||||
|
0.776 | 0.320 | 15 | 90761015 | stop gained | C/A;T | snv | 4.1E-06; 1.4E-04 | 1.7E-04 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.030 | 1.000 | 3 | 2012 | 2015 | ||||||
|
0.776 | 0.320 | 15 | 90761015 | stop gained | C/A;T | snv | 4.1E-06; 1.4E-04 | 1.7E-04 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.030 | 1.000 | 3 | 2012 | 2015 | ||||||
|
1.000 | 0.120 | 15 | 90785079 | stop gained | C/T | snv |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases; Immune System Diseases | 0.700 | 1.000 | 2 | 2008 | 2015 | ||||||||
|
1.000 | 0.120 | 15 | 90803577 | stop gained | C/T | snv | 8.0E-06 | 2.1E-05 |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases; Immune System Diseases | 0.700 | 1.000 | 2 | 2007 | 2013 | ||||||
|
1.000 | 0.120 | 15 | 90754932 | stop gained | TG/- | delins |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases; Immune System Diseases | 0.700 | 1.000 | 1 | 2016 | 2016 | ||||||||
|
0.776 | 0.320 | 15 | 90761015 | stop gained | C/A;T | snv | 4.1E-06; 1.4E-04 | 1.7E-04 |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases | 0.010 | < 0.001 | 1 | 2015 | 2015 | ||||||
|
0.776 | 0.320 | 15 | 90761015 | stop gained | C/A;T | snv | 4.1E-06; 1.4E-04 | 1.7E-04 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2015 | 2015 | ||||||
|
0.776 | 0.320 | 15 | 90761015 | stop gained | C/A;T | snv | 4.1E-06; 1.4E-04 | 1.7E-04 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2015 | 2015 | ||||||
|
0.776 | 0.320 | 15 | 90761015 | stop gained | C/A;T | snv | 4.1E-06; 1.4E-04 | 1.7E-04 |
|
Neoplasms; Male Urogenital Diseases | 0.010 | 1.000 | 1 | 2013 | 2013 | ||||||
|
0.776 | 0.320 | 15 | 90761015 | stop gained | C/A;T | snv | 4.1E-06; 1.4E-04 | 1.7E-04 |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases | 0.010 | < 0.001 | 1 | 2015 | 2015 |